Darius Lakdawalla Elected to National Academy of Medicine
Professor Lakdawalla, a Cornerstone Research affiliated expert, is recognized for transformative work in health policy and economics.
American Conference Institute: Pharma & Biotech Patent Litigation Conference
Darius Lakdawalla of the University of Southern California will discuss antitrust issues in the life sciences at this annual conference.
An empirical study of the impact of mergers and acquisitions on pharmaceutical innovation
This article uses insights from drug launches to investigate the association between M&As and innovation.
340B Drug Pricing Program
Cornerstone Research professionals and experts have analyzed the 340B drug pricing program and its role in the pharmaceutical industry.
American Health Law Association Annual Meeting 2025
Penka Kovacheva and Maria Salgado of Cornerstone Research will speak at this conference focused on legal issues facing healthcare clients.
ASHEcon 2025: The Annual Conference of the American Society of Health Economists
Cornerstone Research staff and affiliated experts will speak at this annual conference hosted by the American Society of Health Economists in Nashville.
ISPOR 2025: Collaborating to Improve Healthcare Decision Making for All
Darius Lakdawalla of the University of Southern California will moderate and speak on several panels at this annual conference.
5 Questions with Jonah Berger: Using Artificial Intelligence and Machine Learning in Litigation
Wharton Professor Jonah Berger speaks on the role of artificial intelligence (AI) and machine learning (ML) in litigation.
Pricing Rules: The Inflation Reduction Act’s Impacts on Pricing in the Life Sciences Industry
The speakers discuss the IRA, including its impacts on innovation, competition, and pricing in the life sciences industry.
Pharma Law USA
Benjamin Fuller of Cornerstone Research will discuss the 340B drug program at this conference hosted by Informa Connect in Boston.
Hatching a Procompetitive Settlement
Celeste Saravia of Cornerstone Research will join attorneys and a regulator at this webinar hosted by the Section of Antitrust Law of the American Bar Association.
Mergers in Life Sciences
In recent years, regulators have expanded their theories of potential anticompetitive harm from mergers in the life sciences industry.
How can we help you?
If you are looking for a publication not on our website, contact us.